Anti-mTOR antibody [EPR390(N)] (Ab134903)
FRAP, FRAP1, FRAP2, RAFT1, RAPT1, MTOR, Serine/threonine-protein kinase mTOR, FK506-binding protein 12-rapamycin complex-associated protein 1, FKBP12-rapamycin complex-associated protein, Mammalian target of rapamycin, Mechanistic target of rapamycin, Rapamycin and FKBP12 target 1, Rapamycin target protein 1, Tyrosine-protein kinase mTOR, mTOR
用户验证的应用
推荐稀释比例
- IHC-PPerform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB1/10000
详细信息
背景信息
What is this antibody validated in? Anti-mTOR antibody [EPR390(N)] (ab134903) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples. What is the molecular weight of mTOR? Anti-mTOR [EPR390(N)] (ab134903) specifically detects a band for mTOR (UniProt: P42345) at a molecular weight of 289kDa. Trusted by the scientific community Anti-mTOR [EPR390(N)] (ab134903) was first used in a scientific publication in 2012 and has been cited over 120 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Specificity confirmed The specificity of Anti-mTOR antibody [EPR390(N)] (ab134903) has been confirmed by Western blot testing in MTOR Knockout HEK293T cells. Other related products We have a range of other formats of antibody clone [EPR390(N)] also available for your convenience: ab134903, Carrier free - ab248718 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (233)
Targeted inhibition of RGS19 alleviates renal fibrosis by restoring autophagy and modulating immune cell infiltration.
靶向抑制 RGS19 可通过恢复自噬和调节免疫细胞浸润来缓解肾纤维化。
Bacteriocin-transport-inspired oral peptide-probiotic delivery ameliorates IBD complications via autophagy and gut homeostasis.
受细菌素运输启发的口服肽益生菌递送通过自噬和肠道稳态改善 IBD 并发症。
INHBA, regulated by C/EBPβ, induces M2 macrophage polarization to promote tumor metastasis and growth via activating the PI3K/AKT pathway in gastric cancer.
INHBA 受 C/EBPβ 调控，诱导 M2 巨噬细胞极化，通过激活胃癌中的 PI3K/AKT 通路促进肿瘤转移和生长。
FGFR2 is a Candidate Immune-Associated Marker of Diabetic Foot Ulcer That Promotes Keratinocyte Function by Activating the PI3K/Akt and MAPK Pathways.
FGFR2 是糖尿病足溃疡的候选免疫相关标志物，它通过激活 PI3K/Akt 和 MAPK 通路促进角质形成细胞功能。
Cycloastragenol Inhibits Colorectal Cancer Cell Metastasis via Epithelial-Mesenchymal Transition and the PI3K Signalling Pathway.
环阿斯特拉醇通过上皮-间质转化和PI3K信号通路抑制结直肠癌细胞转移。
Mechanisms of hesperetin in alleviating diabetic nephropathy: Network pharmacology, molecular docking, and experimental validation.
橙皮苷缓解糖尿病肾病的机制：网络药理学、分子对接和实验验证。
Intervention of Rutin and Ochnaflavone in the Attenuation of Neuroinflammation and Neuronal Apoptosis in Spinal Cord Injury.
芦丁和金盏花酮在脊髓损伤中减轻神经炎症和神经元凋亡的作用。
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
靶向SRSF1可通过双重作用于CD8+T细胞和肿瘤细胞来增强癌症免疫疗法。
SREBP1-mediated lipogenesis promotes dedifferentiation and senescence of vascular smooth muscle cells through epigenetic remodeling.
SREBP1介导的脂肪生成通过表观遗传重塑促进血管平滑肌细胞的去分化和衰老。
A TEMPO-loaded DNA hydrogel enabling integrated early diagnosis and treatment of osteoarthritis.
载有TEMPO的DNA水凝胶可实现骨关节炎的早期诊断和治疗。
- 1
- 2
- 3
- 4
- 5
- 6
- 24